HP moves into life sciences, while microfluidics market sees a surge in patent filings and suits

A new analysis of the thriving synthetic biology patent landscape has revealed the top patent owners and dealmakers in this space, as well as those appearing most often in the courtroom. Among its key findings are that Hewlett Packard (HP) has…


Get unlimited access to all IAM content